PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.50
Bid: 67.00
Ask: 80.00
Change: 3.50 (5.00%)
Spread: 13.00 (19.403%)
Open: 70.00
High: 73.50
Low: 65.00
Prev. Close: 70.00
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CCI Exclusive Distributor Agreement with Korea ISG

8 Jun 2017 13:15

RNS Number : 5678H
Feedback PLC
08 June 2017
 

8 June 2017

Feedback plc

 

("Feedback" or the "Company")

 

CCI Exclusive Distributor Agreement with Korea ISG

 

Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to announce that its subsidiary Cambridge Computed Imaging Ltd ("CCI") has signed an Exclusive Distributor arrangement with Korea Computer Motion ISG ("Korea ISG") based in Seoul, South Korea, for sales and distribution of its TexRAD® texture analysis research software ("TexRAD").

TexRAD will be used by customers for research purposes, performing advanced analysis of routinely acquired medical diagnostic images (e.g. CT, MRI) in South Korea.

As outlined in CCI's recent investor presentations, this is a significant step for CCI as part of its plans to expand sales of TexRAD software to meet the fast-growing demand in Asian markets, identifying and engaging with distributors who are experts in the local market, and who can leverage the TexRAD brand awareness to help build a regional sales pipeline.

Dr Balaji Ganeshan, CEO of TexRAD and Director of New Business at Feedback said:

 "We are pleased to sign this significant Distributorship agreement with Korea ISG to support the interest and acceptance of TexRAD in the rapidly growing and important South Korean medical imaging research market. We are confident that by working with an experienced team led by the CEO Jacob Woo, who has a great understanding of the market and customer base, we stand to increase the TexRAD revenue potential and market reach and meet our customer needs."

Mr Jacob Woo, CEO of Korea ISG commented, "

"We are pleased to have started to work with CCI this year to promote the highly acclaimed TexRAD texture analysis software in South Korea which has attracted a lot of interest amongst the top university hospitals who are also our potential customers. Following a recent installation for research at the prestigious Korea University Hospital, I anticipate a very successful business relationship, rapidly increasing TexRAD software sales and working closely with Dr. Balaji Ganeshan and CCI. Our team has a first class reputation amongst researchers in the region, and offers unrivalled in-depth market-access and know-how in South Korea."

 

About CCI

CCI Ltd is owned by Feedback, based in Bourn, Cambridge, UK. CCI focusses on the development and supply of advanced software including TexRAD, for texture analysis of medical images and storage and interpretation of imaging data.

About Korea Motion ISG

Korea ISG has installed and supported MRI/CT 3D processing imaging software to about 120 prominent Korean hospitals for 23 years, and is the largest medical imaging software distribution (sales and service/support) company in South Korea. They are experienced distributors of medical software from other world leading suppliers, with a wide customer base.

About TexRAD

TexRAD is a highly advanced, patented image texture analysis software tool that analyses routinely acquired diagnostic medical images (e.g. CT, MRI) to reveal features that are not always evident to the human eye. The platform also comprises a novel data-mining tool to assist the research customer to undertake statistical analysis to identify interesting parameters demonstrating association with patient outcome and clinical parameters. A number of research studies published in numerous peer-reviewed journals and conference presentations show that TexRAD texture metrics may have the potential to predict prognosis, disease severity and treatment prediction/evaluation in a number of cancer applications.

 

 

For further information, please contact:

Feedback plcAlastair Riddell

Tel: 01954 718072

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAOKFDKBBKDCAK
Date   Source Headline
3rd May 20117:00 amRNSChange of Adviser
25th Feb 20114:04 pmRNSDirector/PDMR Shareholding
22nd Feb 20118:00 amRNSHalf Yearly Report
18th Feb 20114:16 pmRNSDirectorate Change
11th Feb 201111:58 amRNSDirectorate Change
29th Nov 201010:08 amRNSDirector/PDMR Shareholding
29th Oct 20107:00 amRNSFinal Results
29th Apr 20107:00 amRNSDirector/PDMR Shareholding
28th Apr 20107:00 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSInterim Results
30th Oct 200911:30 amRNSFinal Results
12th Aug 20097:00 amRNSDirectorate Change
17th Feb 20097:00 amRNSHalf Yearly Report
8th Dec 20084:42 pmRNSDirectorate Change
19th Nov 20087:00 amRNSDirector/PDMR Shareholding
23rd Oct 20087:00 amRNSDirector/PDMR Shareholding
15th Oct 20084:59 pmRNSDirector/PDMR Shareholding
9th Oct 20087:00 amRNSFinal Results
2nd Jun 200812:37 pmRNSHolding(s) in Company
30th May 20085:38 pmRNSTotal Voting Rights
21st May 200811:45 amRNSResult of EGM
24th Apr 20087:55 amRNSProperty Purchase
4th Apr 20087:01 amRNSDirectorate Change
26th Mar 200810:06 amRNSDirectorate Change
28th Feb 20088:06 amRNSInterim Results
11th Feb 20089:21 amRNSUpdate on CVA
10th Jan 20087:00 amRNSDirectorate Change
10th Dec 20075:23 pmRNSCapital Reorganisation
10th Dec 20074:00 pmRNSCapital Reorganisation
13th Nov 20077:00 amRNSDirectorate Change
26th Oct 20073:45 pmRNSDirector/PDMR Shareholding
25th Oct 20071:13 pmRNSOffer Talks Terminated
17th Oct 20071:39 pmRNSStatement re Possible Offer
27th Sep 20077:01 amRNSFinal Results
16th Aug 20079:02 amRNSAIM Rule 26 Information
31st Jul 20073:45 pmRNSTotal Voting Rights
25th Jul 20078:26 amRNSDirectorate Change
20th Jul 20074:41 pmRNSDirector/PDMR Shareholding
18th Jul 20074:07 pmRNSHolding(s) in Company
17th Jul 20071:06 pmRNSHolding(s) in Company
9th Jul 20074:30 pmRNSHolding(s) in Company
5th Jul 200710:16 amRNSHolding(s) in Company
2nd Jul 20071:07 pmRNSResult of EGM
5th Jun 20077:02 amRNSIssue of Equity
2nd May 200711:03 amRNSHolding(s) in Company
30th Apr 200712:28 pmRNSTotal Voting Rights
30th Mar 200710:16 amRNSTotal Voting Rights
2nd Mar 20072:31 pmRNSIssue of Equity
7th Feb 20077:01 amRNSUpdate on Property Disposal
21st Dec 200611:29 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.